MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mutation screening and burden analysis of AOPEP in dystonia in a Chinese population

    J. Lin, C. Li, H. Shang (Chengdu, China)

    Objective: To explore the genetic involvement of AOPEPin dystonia in East Asian population. Background: Recently, AOPEPwas identified to be a novel likely causative gene of autosomal recessive dystonia.…
  • 2022 International Congress

    Automated error detection when applying the protocol for the monitoring of motor function in patients with Parkinson’s disease using smartwatches.

    L. Sigcha, JM. Cermeño, MB. Domínguez, I. Pavón, JC. Matínez, JM. López, G. de Arcas (Madrid, Spain)

    Objective: To validate an automatic classification system for the identification of errors in the performance of standardized MDS-UPDRS III exercises by using inertial sensors from…
  • 2022 International Congress

    Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

    S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)

    Objective: We aim to characterize the contribution of each midbrain cell type to PD pathology, and to identify cell types associated with genetic PD-risk variants.…
  • 2022 International Congress

    NONINVASIVE BRAINSTEM MODULATION FOR THE TREATMENT OF NONMOTOR SYMPTOMS IN PARKINSON’S DISEASE: A RANDOMIZED CONTROLLED TRIAL AND OPEN LABEL EXTENSION STUDY

    K. Ade (Durham, USA)

    Objective: A multi-site double-blinded pivotal randomized controlled trial (RCT) with an open label extension (OLE) study has been initiated to evaluate the safety and efficacy…
  • 2022 International Congress

    Blood neurofilament light chain as a biomarker of Parkinson’s disease

    S. Ganesh, B. Huxford, A. Zirra, C. Edwards, C. Simonet, T. Haque, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of the study was to analyse blood neurofilament light chain (NfL) levels in patients with Parkinson’s disease (PD) and healthy controls (HCs),…
  • 2022 International Congress

    Feasibility of artificial intelligence in predicting early phenotype conversion of REM Sleep Behavior Disorder

    L. Lopes, P. Wu, J. Lu, J. Wang, C. Bassetti, A. Rominger, C. Zuo, H. Yu, K. Shi (Bern, Switzerland)

    Objective: The goal of this study was to investigate the feasibility of deep learning in the prediction of disease conversion in RBD patients. Background: Rapid…
  • 2022 International Congress

    Sleep stability, arousals and cycle structure in alfa-synucleinopathies: a comparative study between isolated REM sleep behaviour disorder (iRBD), Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB)

    M. Magriço, P. Bugalho (Lisboa, Portugal)

    Objective: To compare sleep stability, arousals and sleep cycle structure between two sets of diagnosis: iRBD vs PD vs DLB; patients with RBD (RBD+) vs…
  • 2022 International Congress

    It takes a village: An interdisciplinary care model for atypical Parkinsonism

    H. Glover, J. Shurer, M. Ivancic, M. Sklerov (Chapel Hill, USA)

    Objective: To describe one interdisciplinary clinic designed to offer comprehensive care to patients with atypical parkinsonism syndromes, and to share the lessons learned which may…
  • 2022 International Congress

    High- and Low-Frequency Deep Brain Stimulation in the Subthalamic Nucleus differentially modulate Response Inhibition and Action Selection in Parkinson’s Disease

    J. Waldthaler, A. Sperling, A. König, F. Bremmer, L. Timmermann, D. Pedrosa (Marburg, Germany)

    Objective: The aim of this project was to investigate how high- and low-frequency deep brain stimulation (DBS) modulate impulsive actions in the antisaccade task as…
  • 2022 International Congress

    Coexistence of Parkinson’s Disease and Myasthenia Gravis: Disease Characteristics and Confusion

    Z. Mao, Q. Nie, Z. Li, Z. Xue (Wuhan, China)

    Objective: In order to alert clinicians to the possibility of the coexistence of the two diseases and optimize the management of both conditions. Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 401
  • 402
  • 403
  • 404
  • 405
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley